UBS Group
TNON icon

UBS Group’s Tenon Medical TNON Stock Holding History

UBS Group’s Portfolio TNON Stock Details TNON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-119
Closed -$2.86K – 10389
2026
Q1 		$3.03K Sell
119
-62
-34% -$1.83K ﹤0.01% 9154
2025
Q4 		$6.02K Buy
181
+119
+192% +$4.79K ﹤0.01% 8595
2025
Q3 		$2.57K Sell
62
-275
-82% -$11.7K ﹤0.01% 9152
2025
Q2 		$11.5K Sell
337
-46
-12% -$1.76K ﹤0.01% 8781
2025
Q1 		$28.3K Buy
383
+318
+489% +$17.9K ﹤0.01% 7984
2024
Q4 		$4.31K Buy
+65
New +$6.67K ﹤0.01% 8766
2024
Q3 		– Hold
0
– -$20 – 10066
2024
Q2 		– Hold
0
– – – 9308
2024
Q1 		– Hold
0
– -$158 – 10017
2023
Q4 		– Hold
0
– – – 8858
2023
Q2 		– Sell
-1
Closed -$3.66K – 9656
2023
Q1 		$3.66K Hold
1
– – ﹤0.01% 8292
2022
Q4 		$3.96K Buy
+1
New +$5.1K ﹤0.01% 9420

Other funds holding TNON

WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $360M AUM 19.03% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group's TNON Position: Q2 2026 in Review

UBS Group sold out of Tenon Medical (TNON) in Q2 2026, closing a stake of 119 shares — an estimated $2.86K sold.

UBS Group first reported a position in TNON in Q4 2022 and held it in 8 quarters. The position peaked at $28.3K in Q1 2025. 13 funds tracked by Wall St. Rank hold TNON as of Q2 2026.

  • UBS Group reported no remaining Tenon Medical position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 119 Tenon Medical shares in Q2 2026, an estimated $2.86K.
  • UBS Group first reported a position in Tenon Medical in Q4 2022 and held it in 8 quarters.
  • UBS Group's Tenon Medical position peaked at $28.3K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held Tenon Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.